Related Experiment Video
Updated: Jul 28, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
We need to talk about lung cancer's cholesterol-hoarding problem.
1Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.
Lung cancers accumulate cholesterol by altering lipid trafficking. Cholesterol-lowering therapies may be a promising strategy for treating non-small cell lung cancer.
Area of Science:
- Oncology
- Lipid Metabolism
- Cancer Biology
Background:
- Proliferative cells, including cancer cells, have increased cholesterol requirements for membrane biogenesis.
- Non-small cell lung cancer (NSCLC) is a major cause of cancer-related mortality.
- Aberrant lipid metabolism is increasingly recognized as a hallmark of cancer.
Purpose of the Study:
- To investigate how KRAS-mutant non-small cell lung cancer (NSCLC) acquires excess cholesterol.
- To explore the role of lipid trafficking in cholesterol accumulation in NSCLC.
- To assess the therapeutic potential of cholesterol-modulating interventions in NSCLC.
Main Methods:
- Utilized a mutant KRAS mouse model of non-small cell lung cancer.
- Analyzed cholesterol accumulation and lipid trafficking patterns within lung tumors.
- Evaluated the effects of cholesterol-removing interventions on tumor progression.
Main Results:
- KRAS-mutant lung cancers exhibit significant cholesterol accumulation.
- Cholesterol levels are modulated through reprogramming of both local and distal lipid trafficking pathways.
- Targeting cholesterol metabolism demonstrated a potential therapeutic effect in this NSCLC model.
Conclusions:
- Non-small cell lung cancer cells actively reprogram lipid trafficking to meet their high cholesterol demands.
- Cholesterol accumulation is a critical feature of KRAS-driven lung tumorigenesis.
- Interventions aimed at reducing cholesterol levels represent a potential therapeutic avenue for NSCLC.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...

